About The Work
MediGO’s innovative healthcare supply chain technology digitally transforms the U.S. organ donation and transplant system to improve fairness and equity, reduce nonuse of donated organs, and save more lives. Recognized by Edison Awards and Fast Company for its disruptive technology, and powered by proprietary algorithms and machine learning, MediGO provides the most actionable data available in the donation and transplantation industry. For more information about MediGO, a JSP Ventures company, visit gomedigo.io.
To learn more about this business, see open positions or make use of their services, please click below.
“Our proven team of supply chain and logistics experts from the private and public sectors have developed tracking and communications platforms for all types of cargo and modes of transportation. Key to MediGO’s development and implementation is the close tie between Organ Procurement Organizations (OPO) and transplant centers. That connection is critical to care for the life-saving gifts of organ donors.”
- Scott Plank
Scott Plank – CEO and Co-Founder
Dr. Joseph Scalea – CMO and Co-Founder
Anthony Pucciarella – Co-Founder
- To increase access to organ transportation by optimizing the transplant supply chain.
- To provide technology that bridges the workflow gaps in organ transportation.
- To enable stakeholders across the transplantation continuum to track organ shipments in real-time, communicate in real-time, and monitor shipment quality to safeguard the irreplaceable gift of life from donors and donor families.